Search results

• 2022

  COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

  Alexander, J. L., Liu, Z., Muñoz sandoval, D., Reynolds, C., Ibraheim, H., Anandabaskaran, S., Saifuddin, A., Castro seoane, R., Anand, N., Nice, R., Bewshea, C., D'mello, A., Constable, L., Jones, G. R., Balarajah, S., Fiorentino, F., Sebastian, S., Irving, P. M., Hicks, L. C., Williams, H. R. T., & 49 othersKent, A. J., Linger, R., Parkes, M., Kok, K., Patel, K. V., Teare, J. P., Altmann, D. M., Goodhand, J. R., Hart, A. L., Lees, C. W., Boyton, R. J., Kennedy, N. A., Ahmad, T., Powell, N., Chukwurah, I., Haq, S., Shah, P., Wilken-Smith, S., Ramanathan, A., Patel, M., Romanczuk, L., King, R., Domingo, J., Shamtally, D., Mendoza, V., Sanchez, J., Stark, H., Knight, B., Bee, L., Estember, C., Barnes, A., Watkins, D., Stone, S., Kirkwood, J., Parkinson, M., Gardner-Thorpe, H., Covil, K., Derikx, L., Gros alcalde, B., Lee, I., Cipriano, B., Ruocco, G., Baden, M., Cooke, G., Pollock, K., Kourampa, E., Pasquale, C., Robisco-Diaz, E. & Bhatti, S., 1 Nov 2022, In: The Lancet Gastroenterology & Hepatology. 7, 11, p. 1005-1015

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Antibody 100%
  • T-Cell Response 100%
  • Vaccine 100%
  • Case-Control Study 100%
  • Vasoactive Intestinal Polypeptide 100%
  15 Citations (Scopus)

• COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

  VIP study investigators, 1 Feb 2022, In: The Lancet Gastroenterology and Hepatology. 7, 4, p. 342-352 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • COVID-19 100%
  • Vaccine 100%
  • Antibody Response 100%
  • Vasoactive Intestinal Polypeptide 100%
  • Patient with Inflammatory Bowel Disease 100%
  31 Citations (Scopus)